Kerr Douglas
Chief Medical Officer
Kerr Douglas has filed 7 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 17, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$176K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| DYN | Chief Medical Officer | Sale | 1,556 | $41K | Aug 17 | SEC ↗ | |
| DYN | Chief Medical Officer | Sale | 887 | $16K | Jun 17 | SEC ↗ | |
| DYN | Chief Medical Officer | Sale | 1,564 | $29K | May 14 | SEC ↗ | |
| DYN | Chief Medical Officer | Sale | 904 | $13K | Mar 6 | SEC ↗ | |
| DYN | Chief Medical Officer | Sale | 880 | $18K | Dec 5 | SEC ↗ | |
| DYN | Chief Medical Officer | Sale | 3,552 | $47K | Sep 8 | SEC ↗ | |
| DYN | Chief Medical Officer | Sale | 873 | $12K | Sep 8 | SEC ↗ |